Selected Research on Longvida® Optimized Curcumin:
  1. Broad-spectrum anti-aging effects of low-dose curcumin (as Longvida®) in healthy human subjects.  The Ohio State University, 2011. Manuscript in development
  2. Effects of Longvida® on soluble tau oligomers and cognitive and synaptic deficits.  Frautschy et al. AAIC 2011, Paris France.
  3. Human pharmacokinetics of chronic dosing of Longvida®: Dose-concentration correlation. UCLA, 2011. 
  4. Acute human pharmacokinetics of 40mg curcumin (as Longvida®) leads to therapeutic blood levels. Shah et al. Manuscript submitted 2011.
  5. Efficacy of Longvida® in Stage III human trials, TATA Memorial Centre, Mumbai. Study ongoing.
  6. Impact of Longvida® on soluble tau oligomers and behavioral and synaptic impairment, Ma et al 2011.  Manuscript in publication.
  7. Does Longvida® provide an alternative to diltiazem for lowering mucopolysaccharide levels in Sanfillippo syndrome?  A human case study. Taylor 2010.
  8. Effects of Longvida® in Trisomy 21: Human Case Studies.  Fish, 2010.
  9. Anti-inflammatory effects of Longvida® compared to unformulated curcumin.  University of Rhode Island, 2011.  Manuscript in development
  10. Expression of GFAP in p25 model after dosing of Longvida®.  National University of Singapore, 2011.
  11. Acute human bioavailability of Longvida®: 65x Greater Bioavailability: 65x Greater Bioavailability. Gota et al. J Ag Food Chem 2010 58(4): 2095-2099.
  12. Curcumin bioavailability, activity and mechanism for cognitive health using Longvida®. Begum et al.  J Pharmacol Exp Ther. 2008 Jul;326(1):196-208.
  13. Bioavailability, brain concentrations, activity and dose-response of Longvida® SLCP. Frautschy, SA. 38th Annual Meeting of the Society of Neuroscience , Washington DC, November 15, 2008.
  14. Longvida® synergizes with Omega-3 fatty acids: effects on cognitive mechanisms. Frautschy, SA et al. 39th Annual Meeting of the Society of Neuroscience , Chicago, IL October 2009.
  15. Efficacy of Longvida® in relation to systemic availability in the brain. Frautschy, SA et al. 39th Annual Meeting of the Society of Neuroscience , Chicago, IL October 2009.
  16. Chronic dosing safety assessment of a Solid Lipid Curcumin Particle (Longvida®) formulation.  Dadhaniya et al. Food Chem Toxicol. 2011 Aug; 49(8):1834-42.

    Other Curcumin References:
  17. Aggarwal BB, Bhatt ID, Ichikawa H, Ahn KS, Sethi G, Sandur SK, et al. Turmeric: the genus Curcuma. Taylor and Francis Group; 2006. p. 297–368.
  18. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Mol Pharmacol 2006;69:195–206.
  19. Baum L. et al. Letter in Journal of Clinical Psychopharmacology  Volume 28, Number 1, February 2008 pp110-112.
  20. Began G, Sudharshan E, Appu Rao AG. Lipids 1998;33:1223–8.
  21. Bundy R, Walker AF, Middleton RW, Booth J.  J Altern Complement Med 2004;10:1015–8.
  22. Cheng AL, Hsu CH, Lin JK, et al. Antican Res. 2001;21:2895-2900.
  23. Cho JW, Lee KS, Kim CW. Int J Mol Med 2007;19:469–74.
  24. Conteas CN, Panossian AM, Tran TT, Singh HM. Dig Dis Sci. 2008 Dec 3.
  25. Cruz-Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, Wexner SD, et al.  Clin Gastroenterol Hepatol 2006;4:1035–8
  26. Deodhar SD, Sethi R, Srimal RC. Indian J Med Res 1980;71:632–4.
  27. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Clin Can Res. 2008 Jul 15;14(14):4491-9.
  28. Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, Juyal RC, Pandav R, Belle SH, DeKosky ST. Arch Neurol. 2000 Jun;57(6):824-30.
  29. Garcea G, Berry DP, Jones DJ, Singh R, Dennison AR, Farmer PB, et al. Can Epidemiol Biomarkers Prev 2005;14:120–5.
  30. Goel A, Kunnumakkara AB, Aggarwal BB. Biochem Pharmacol. 2008 Feb 15;75(4):787-809. Epub 2007 Aug 19.
  31. Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, et al. Clin Gastroenterol Hepatol 2006;4:1502–6
  32. Holt PR, Katz S, Kirshoff R.  Dig Dis Sci 2005;50:2191–3.
  33. Lal B, Kapoor AK, Agrawal PK, Asthana OP, Srimal RC.  Phytother Res. 2000;14:443-447.
  34. Lal B, Kapoor AK, Asthana OP, Agrawal PK, Prasad R, Kumar P, et al. Phytother Res 1999;13:318–22.
  35. Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, et al.  BMC Complement Altern Med 2006;6:10.
  36. Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH.  Am J Epidemiol 2006;164:898–906.
  37. Ono et al. J Neurosci Res. 2004 Mar 15;75(6):742-50.
  38. Satoskar RR, Shah SJ, Shenoy SG.  Int J Clin Pharmacol Ther Toxicol 1986;24:651–4.
  39. Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, et al. Clin Can Res 2001;7:1894–900.
  40. Shishodia S, Singh T, Chaturvedi MM. Adv Exp Med Biol 2007;595:127–48.
  41. Shoskes D, Lapierre C, Cruz-Correa M, Muruve N, Rosario R, Fromkin B, et al. Transplantation 2005;80:1556–9
  42. Skrzypczak-Jankun E, Zhou K, McCabe NP, Selman SH, Jankun J.  Int J Mol Med 2003;12:17–24.
  43. Soni KB, Kuttan R. Indian J Physiol Pharmacol 1992;36:273–5.
  44. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, et al.  J Biol Chem 2005;280:5892–901. 

Links
National Institutes of Health (NIH) Database
Society for Neuroscience
Wikipedia - Curcumin page
National Center for Complementary and Alternative Medicine (NCCAM)
 

* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Please consult your healthcare practitioner before taking any medication or health supplements.

NSF Kosher LBD ISO Certified 
Verdure Sciences Inc.